Clinical Trials Logo

Clinical Trial Summary

Randomised controlled trial to investigate the efficacy of adding metronidazole pre-operatively to kefazolin in reducing postpartum infection


Clinical Trial Description

All pregnant patients scheduled for emergency or elective Caesarean section ≥18 years, willing and able to provide informed consent and not receiving antibiotics, will be eligible for recruitment. Patients will be randomised into receiving kefazolin according to current standard of care administered pre-operatively intravenously with placebo (control arm), and kefazolin according to current standard of care administered pre-operatively with metronidazole 500 mg intravenously pre-operatively. Outcome measures will be surgical site infection, urinary tract infection and postpartum endometritis. Five hundred patients will be recruited in each arm ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04792710
Study type Interventional
Source University of Pretoria
Contact Leon C Snyman, PhD
Phone +27834621818
Email leon.snyman@up.ac.za
Status Not yet recruiting
Phase Phase 4
Start date March 8, 2021
Completion date June 30, 2022

See also
  Status Clinical Trial Phase
Completed NCT05632705 - Efficacy of Using a Closing Pack to Reduce Postpartum Sepsis N/A